Population |
Patients with autoimmune thyroid diseases, including Graves’ disease and Hashimoto’s thyroiditis—aged from 0 to 99 years, both genders |
Patients with other autoimmune diseases |
Intervention |
Not applicable |
|
Comparison |
Not applicable |
|
Outcomes |
Salivary alterations quantitative (e.g., hyposalivation) and/or qualitative (e.g., biomolecules) |
Other salivary alterations (e.g., microbiota) |
Study design |
Case-control, cohort and cross-sectional studies |
Literature reviews, case reports, expert opinion, letters to the editor, conference reports |
Published until 27th September 2022 |
Not published in English |